A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery

Anaesthesia

Volumn 67, Issue 9, 2012, Pages 991-998

  Geldner, G ^a   Niskanen, M ^b   Laurila, P ^c   Mizikov, V ^d   Hubler M ^e   Beck, G ^f   Rietbergen, H ^g   Nicolayenko, E ^h  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d PETROVSKY NATIONAL RESEARCH CENTER OF SURGERY   (Russian Federation)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f DR HORST SCHMIDT KLINIKEN   (Germany)

^g MERCK RESEARCH LABORATORIES   (United States)

^h University Hospital 1   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; C REACTIVE PROTEIN; FENTANYL; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PROPOFOL; ROCURONIUM; SUGAMMADEX;

ABDOMINAL PAIN; ADULT; ANESTHESIA INDUCTION; APPENDECTOMY; ARTICLE; BLOOD PRESSURE; CARDIOTOXICITY; CHOLECYSTECTOMY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; LABORATORY TEST; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROMUSCULAR BLOCKING; OPERATING ROOM; PAIN; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SIDE EFFECT; SINGLE BLIND PROCEDURE; SURGICAL PATIENT; TIME; VOMITING;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INTRAVENOUS; CHOLINESTERASE INHIBITORS; ELECTRIC STIMULATION; FEMALE; GAMMA-CYCLODEXTRINS; HEART RATE; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PATIENT SAFETY; PROPOFOL; SAMPLE SIZE; VECURONIUM BROMIDE; YOUNG ADULT;

EID: 84864673336     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2012.07197.x     Document Type: Article

References (19)

1. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiologica Scandinavica 1997; 41: 1095-103.
2. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS,. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesthesia and Analgesia 2008; 107: 130-7.
3. Jones RK, Caldwell JE, Brull SJ, Soto RG,. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24.
4. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME,. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomized, controlled trial. European Journal of Anaesthesiology 2010; 27: 874-81.
5. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gõmez JA,. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Anesthesia and Analgesia 2010; 110: 64-73.
6. Lemmens HJ, El-Orbany MI, Berry J, Morte JB Jr, Martin G,. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine. BMC Anesthesiology 2010; 10: 15.
7. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N,. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology 1999; 91: 693-700.
8. Apfel CC, Kranke P, Eberhart LHJ, Roos A, Roewer N,. Comparison of predictive models of postoperative nausea and vomiting. British Journal of Anaesthesia 2002; 88: 234-40. (Pubitemid 34145001)
9. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW,. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Canadian Journal of Anesthesia 1996; 43: 932-8. (Pubitemid 26323421)
10. Gurusamy KS, Samraj K, Davidson BR,. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database of Systematic Reviews 2009; 2: CD006930.
11. Fisher DM,. Clinical pharmacology of neuromuscular blocking agents. American Journal of Health-System Pharmacy 1999; 56 (Suppl 1): S4-9. (Pubitemid 29259042)
12. Sprague DH,. Severe bradycardia after neostigmine in a patient taking propranolol to control paroxysmal atrial tachycardia. Anesthesiology 1975; 42: 208-10.
13. Feinberg M,. The problems of anticholinergic adverse effects in older patients. Drugs and Aging 1993; 3: 335-48.
14. Kopman AF, Eikermann M,. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 2009; 64 (Suppl 1): 22-30.
15. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ,. A survey of current management of neuromuscular block in the United States and Europe. Anesthesia and Analgesia 2010; 111: 110-9.
16. Bom A, Epemolu O, Hope F, Rutherford S, Thomson K,. Selective relaxant binding agents for reversal of neuromuscular blockade. Current Opinion in Pharmacology 2007; 7: 298-302. (Pubitemid 46731191)
17. Abrishami A, Ho J, Wong J, Yin L, Chung F,. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database of Systematic Reviews 2009; 4: CD007362.
18. Tramör MR, Fuchs-Buder T,. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. British Journal of Anaesthesia 1999; 82: 379-86. (Pubitemid 29112540)
19. Cheng CR, Sessler DI, Apfel CC,. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting? Anesthesia and Analgesia 2005; 101: 1349-55. (Pubitemid 41531870)